Published in J Phys Chem B on February 25, 2010
HIV protein sequence hotspots for crosstalk with host hub proteins. PLoS One (2011) 0.82
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell Biosci (2012) 0.81
GCN2 has inhibitory effect on human immunodeficiency virus-1 protein synthesis and is cleaved upon viral infection. PLoS One (2012) 0.81
Real-time label-free measurement of HIV-1 protease activity by nanopore analysis. Biosens Bioelectron (2014) 0.81
HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe. PLoS One (2016) 0.78
In silico prediction of mutant HIV-1 proteases cleaving a target sequence. PLoS One (2014) 0.76
The impact of Trichoderma reesei Cel7A carbohydrate binding domain mutations on its binding to a cellulose surface: a molecular dynamics free energy study. J Mol Model (2011) 0.75
Ventilator-associated pneumonia with or without toothbrushing: a randomized controlled trial. Eur J Clin Microbiol Infect Dis (2012) 1.64
Evaluation of recombinant Ro/SSA, La/SSB, Sm, and U1 RNP autoantigens in clinical diagnosis. J Clin Lab Anal (1995) 1.45
NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem (2005) 1.19
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. J Antimicrob Chemother (1999) 1.06
Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation. J Soc Gynecol Investig (2000) 1.01
Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol (2000) 1.01
Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis (2001) 0.97
Protein-ligand docking in the new millennium--a retrospective of 10 years in the field. Curr Med Chem (2013) 0.95
Gemcitabine: a critical nucleoside for cancer therapy. Curr Med Chem (2012) 0.92
Nuclear factor kappa B: a potential target for anti-HIV chemotherapy. Curr Med Chem (2003) 0.91
The contribution of mild thiamine deficiency and ethanol consumption to central cholinergic parameter dysfunction and rats' open-field performance impairment. Pharmacol Biochem Behav (2001) 0.91
Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases. Mini Rev Med Chem (2012) 0.86
Chromophobe renal cell carcinoma: clinicopathological study of 7 cases. Ultrastruct Pathol (1998) 0.82
Understanding the importance of the aromatic amino-acid residues as hot-spots. Biochim Biophys Acta (2012) 0.80
Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy. Eur J Clin Microbiol Infect Dis (2011) 0.79
Determination of the DeltapKa between the active site cysteines of thioredoxin and DsbA. J Comput Chem (2006) 0.79
[Five cases of zygomycosis.]. Rev Iberoam Micol (1999) 0.79
Detailed microscopic study of the full zipA:FtsZ interface. Proteins (2006) 0.78
MADAMM: a multistaged docking with an automated molecular modeling protocol. Proteins (2009) 0.78
Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis. Curr Med Chem (2013) 0.78
The search for a new model structure of beta-factor XIIa. J Comput Aided Mol Des (2001) 0.78
Inclusion of conserved buried water molecules in the model structure of rat submaxillary kallikrein. J Comput Aided Mol Des (1997) 0.78
Ribonucleotide reductase: a mechanistic portrait of substrate analogues inhibitors. Curr Med Chem (2010) 0.77
Carotid bifurcation atherosclerosis in the over-65s: a prevalence study. J Cardiovasc Surg (Torino) (2008) 0.77
Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead. J Mol Graph Model (2007) 0.77
Molecular dynamics model of unliganded HIV-1 reverse transcriptase. Med Chem (2006) 0.76
Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis. J Mol Model (2014) 0.76
The catalytic mechanism of carboxylesterases: a computational study. Biochemistry (2014) 0.76
ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease. Mini Rev Med Chem (2009) 0.76
New designs for MRI contrast agents. J Comput Aided Mol Des (2003) 0.76
Sympathetic sudomotor function and aging. Muscle Nerve (1995) 0.76
Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs). J Biomol Struct Dyn (2013) 0.75
Qualitative and quantitative analysis of poly(amidoamine) dendrimers in an aqueous matrix by liquid chromatography-electrospray ionization-hybrid quadrupole/time-of-flight mass spectrometry (LC-ESI-QTOF-MS). Anal Bioanal Chem (2013) 0.75
[Autonomic disorders of central origin]. Med Clin (Barc) (1994) 0.75
Y body association with morphologic heterogeneity of human sperm. Int J Fertil Menopausal Stud (1994) 0.75
Male infertility: the use and efficacy of frozen sperm. Curr Opin Obstet Gynecol (1990) 0.75
The mechanism of the Ser-(cis)Ser-Lys catalytic triad of peptide amidases. Phys Chem Chem Phys (2017) 0.75
Flocculation of Saccharomyces cerevisiae is induced by transformation with the GAP1 gene from Kluyveromyces marxianus. Yeast (2000) 0.75
Structural analysis of 2-piperidin-4-yl-actamide derivatives for hERG blocking and MCH R1 antagonistic activities. Curr Drug Discov Technol (2012) 0.75
Autonomic profile of subjects prone to fainting. J Neurol Sci (1996) 0.75
[Pulmonary changes in different forms of intracranial hemorrhage]. Arq Bras Cardiol (1985) 0.75
[Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome]. Neurologia (1994) 0.75
Evaluation of congenital dysautonomia other than Riley-Day syndrome. Neuropediatrics (1996) 0.75
The nature of trypsin-pancreatic trypsin inhibitor binding: free energy calculation of Tyr39-->Phe39 mutation in trypsin. J Pept Res (1997) 0.75
Understanding the Mechanism for Ribonucleotide Reductase Inactivation by 2'- Deoxy-2'-methylenecytidine-5'-diphosphate. J Chem Theory Comput (2010) 0.75
Analysis of van der Waals surface area properties for human ether-a-go-go-related gene blocking activity: computational study on structurally diverse compounds. SAR QSAR Environ Res (2012) 0.75
[Uncommon parasitism in the central adrenal vein of chronic patients with Chagas' disease]. Arq Bras Cardiol (1986) 0.75